Nojima, Ichiro
Eikawa, Shingo
Tomonobu, Nahoko
Hada, Yoshiko
Kajitani, Nobuo
Teshigawara, Sanae
Miyamoto, Satoshi
Tone, Atsuhito
Uchida, Haruhito A.
Nakatsuka, Atsuko
Eguchi, Jun
Shikata, Kenichi
Udono, Heiichiro
Wada, Jun
Funding for this research was provided by:
Japan Society for the Promotion of Science (19H03675)
Article History
Received: 17 March 2020
Accepted: 24 August 2020
First Online: 10 September 2020
Competing interests
: Haruhito A. Uchida belongs to the Department of Chronic Kidney Disease and Cardiovascular Disease which is endowed by Kawanishi Holdings, Chugai pharmaceutical, Boehringer Ingelheim and Terumo Corporation. Jun Wada receives speaker honoraria from Astellas, Astra Zeneca, Boeringer Ingelheim Japan, Daiichi Sankyo, MSD, Novartis, Tanabe Mitsubishi, Taisho Toyama and receives grant support from Bayer, Baxter, Chugai, Dainippon Sumitomo, Kyowa Hakko Kirin, MSD, Novartis, Novo Nordisk, Ono, Takeda, Tanabe Mitsubishi, Teijin. Other authors have no competing interests.